<DOC>
	<DOCNO>NCT00523952</DOCNO>
	<brief_summary>Objective : Assess efficacy safety tacrolimus ointment use adult moderate severe atopic dermatitis . The ointment apply affected skin twice daily 3 week daily lesion clear</brief_summary>
	<brief_title>Clinical Trial Assess Efficacy Safety Tacrolimus Ointment Treatment Atopic Dermatitis Adult Patients</brief_title>
	<detailed_description>The study one arm non-comparative study . The study medication Tacrolimus ointment 0.1 % ( Protopic ® 0.1 % ) .</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>Male female , ethnic group , age ≥16 Moderate severe atopic dermatitis Has give inform consent Erythroderma Pregnant breastfeed Skin infection affect area</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>dermatitis , atopic</keyword>
	<keyword>tacrolimus</keyword>
	<keyword>adult</keyword>
</DOC>